| Literature DB >> 28164711 |
David E Williams1, Doralyn S Dalisay1,2, Jessie Chen3, Elena A Polishchuck3, Brian O Patrick3, Gagandeep Narula4, Mary Ko4, Yossef Av-Gay4, Haoxin Li5, Nathan Magarvey5, Raymond J Andersen1.
Abstract
The new ansa macrolide antibiotics 1 to 4 have been isolated from cultures of a Micromonospora sp. obtained from a marine sediment. Rifamycins 1 and 2 are the first natural ansa macrolides to have a 3-amino substituent. Sporalactams A (3) and B (4) are comprised of a heterocylic core 5 and a 14-membered ansa bridge that are both unprecedented. Sporalactam B (4) shows selective and potent inhibition of Mycobacterium tuberculosis.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28164711 DOI: 10.1021/acs.orglett.6b03619
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005